This paper highlights Wharton’s jelly — a tissue in the human umbilical cord that is typically discarded at birth — as a viable source for mesenchymal stem cells. These cells are young, abundant, and ethically sourced.

For patients receiving cell-based or exosome therapies, this article explains why Wharton’s jelly has become one of the most preferred sources for regenerative medicine.

This is a research reference from our clinical library. Approved by the Chambers Clinic Team — last reviewed May 28, 2026.